Sulfonylurea use and the risk of hospital readmission in patients with type 2 diabetes

被引：0
|
作者：
Pamela C. Heaton
Vibha C. A. Desai
Christina M. L. Kelton
Swapnil N. Rajpathak
机构：
[1] University of Cincinnati Academic Health Center,Pharmacy Practice and Administrative Sciences, James L. Winkle College of Pharmacy
[2] HealthCore,Carl H. Lindner College of Business
[3] University of Cincinnati,undefined
[4] US Outcomes Research,undefined
[5] Merck & Co.,undefined
[6] Inc.,undefined
来源：
BMC Endocrine Disorders | / 16卷
关键词：
Sulfonylureas; Oral antihyperglycemic agents; Type 2 diabetes; Hospital readmissions;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Sulfonylurea use and the risk of hospital readmission in patients with type 2 diabetes
    Heaton, Pamela C.
    Desai, Vibha C. A.
    Kelton, Christina M. L.
    Rajpathak, Swapnil N.
    BMC ENDOCRINE DISORDERS, 2016, 16
  • [2] The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment
    Pan, Sheng-Wei
    Yen, Yung-Feng
    Kou, Yu Ru
    Chuang, Pei-Hung
    Su, Vincent Yi-Fong
    Feng, Jia-Yih
    Chan, Yu-Jiun
    Su, Wei-Juin
    CHEST, 2018, 153 (06) : 1347 - 1357
  • [3] Pharmacoeconomic aspects of the use of sulfonylurea drugs in type 2 diabetes mellitus
    Rudakova, A. V.
    DIABETES MELLITUS, 2011, 14 (03): : 111 - 112
  • [4] Genetic risk factors for type 2 diabetes mellitus and response to sulfonylurea treatment
    Swen, Jesse J.
    Guchelaar, Henk-Jan
    Baak-Pablo, Renee F.
    Assendelft, Willem J. J.
    Wessels, Judith A. M.
    PHARMACOGENETICS AND GENOMICS, 2011, 21 (08) : 461 - 468
  • [5] Risk factors associated with 30-day readmission and length of stay in patients with type 2 diabetes
    Enomoto, Laura M.
    Shrestha, Deepika P.
    Rosenthal, Meredith B.
    Hollenbeak, Christopher S.
    Gabbay, Robert A.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (01) : 122 - 127
  • [6] Sulfonylurea monotherapy and emergency room utilization among elderly patients with type 2 diabetes
    Rajpathak, Swapnil N.
    Fu, Chunmay
    Brodovicz, Kimberley
    Engel, Samuel S.
    Heaton, Pamela C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 109 (03) : 507 - 512
  • [7] Sulfonylurea treatment of type 2 diabetes mellitus: Focus on glimepiride
    Korytkowski, MT
    PHARMACOTHERAPY, 2004, 24 (05): : 606 - 620
  • [8] Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients
    Susilawati, Elis
    Levita, Jutti
    Susilawati, Yasmiwar
    Sumiwi, Sri Adi
    MEDICAL SCIENCES, 2023, 11 (03)
  • [9] Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) - a study protocol
    Schrijnders, Dennis
    de Bock, Geertruida H.
    Houweling, Sebastiaan T.
    van Hateren, Kornelis J. J.
    Groenier, Klaas H.
    Johnson, Jeffrey A.
    Bilo, Henk J. G.
    Kleefstra, Nanne
    Landman, Gijs W. D.
    BMC CANCER, 2017, 17
  • [10] Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol
    Dennis Schrijnders
    Geertruida H. de Bock
    Sebastiaan T. Houweling
    Kornelis J. J. van Hateren
    Klaas H. Groenier
    Jeffrey A. Johnson
    Henk J. G. Bilo
    Nanne Kleefstra
    Gijs W. D. Landman
    BMC Cancer, 17
12345